Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Caspase-3 Colorimetric Assay Kit: Practical Guide
2026-09-13
The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a DEVD-dependent biochemical readout of active caspase-3 in lysed biological samples. It is useful for apoptosis assay workflows and comparative caspase activity measurement, but the colorimetric signal should not be treated as standalone proof of apoptosis or as a substitute for orthogonal validation.
-
Necrostatin-1: From RIP1 Mechanism to Translation
2026-09-12
Necrostatin-1 is a selective allosteric RIP1 kinase inhibitor for dissecting necroptosis, inflammatory injury, and acute kidney injury research. This article connects pathway biology, assay design, ferroptosis-related findings, and translational strategy beyond a conventional product description.
-
Hoechst 33258: Bis-Benzimide DNA Stain
2026-09-11
Hoechst 33258 is a cell-permeable bis-benzimide DNA stain for nuclear visualization, live-cell labeling, fixed-cell imaging, and flow-cytometric cell-cycle analysis. Its AT-rich minor-groove binding produces approximately 461 nm blue fluorescence after excitation near 350 nm, while tumor pH studies require independent lactate and pH measurements.
-
Recombinant Mouse SHH: Assay Reliability Guide
2026-09-11
Learn how to use Recombinant Mouse SHH (SKU P1230) to design better proliferation, viability, alkaline phosphatase, and developmental patterning experiments. This scenario-based guide covers potency anchoring, reconstitution, storage, cross-species interpretation, and practical vendor selection.
-
Demethyleneberberine in Huntington’s Disease
2026-09-10
The reference paper proposes Demethyleneberberine (DMB) as a multi-pathway candidate for Huntington’s disease by connecting oxidative stress, mitochondrial dysfunction, neuroinflammation, and neuronal apoptosis. Its main contribution is a mechanistic hypothesis rather than direct therapeutic validation, making the work most useful for designing focused preclinical experiments.
-
Mianserin HCl: From Receptor Biology to Translation
2026-09-10
Mianserin HCl offers translational researchers more than a conventional antidepressant model: it connects 5-HT2 receptor pharmacology, cyclodextrin-enabled formulation, cytotoxicity, and antipathogenic investigation within a strategically disciplined workflow.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-09
Hydroxychloroquine Sulfate provides an aqueous-compatible perturbation for studying autophagy pathway modulation and TLR7/9-dependent responses in autoimmune disease research. It is suited to short-term, water-based workflows, but not to protocols requiring DMSO or ethanol solubility, long-term solution storage, or unvalidated animal dosing.
-
Dlin-MC3-DMA for Smarter LNP RNA Delivery
2026-09-09
Dlin-MC3-DMA is an ionizable cationic liposome lipid for building potent LNPs that support hepatic siRNA delivery and mRNA vaccine formulation. This practical guide connects its pH-responsive behavior with formulation workflow, machine-learning-guided optimization, comparative performance, and troubleshooting decisions.
-
Direct Mouse Genotyping Kit Plus for Study Integrity
2026-09-08
The Direct Mouse Genotyping Kit Plus supports a genotype-first strategy for reliable mouse genotyping assay design. This article connects rapid direct PCR with mechanistic studies of SCA3/MJD mice, showing how pre-analytic genetic quality control strengthens interpretation without overstating what genotype data can prove.
-
MK-0812 Workflows for CCR2 Inflammation Research
2026-09-08
MK-0812 enables precise interrogation of CCR2-dependent monocyte trafficking from whole-blood pharmacology to gut–liver inflammation models. This practical guide connects validated MCP-1 blockade with experimental designs for MASH mechanism studies while clearly separating established performance from exploratory applications.
-
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-09-07
The reference study identifies the RNA-binding protein RBMS1 as a post-transcriptional regulator of PD-L1 stability in triple-negative breast cancer. Its depletion destabilizes B4GALT1 mRNA, reduces PD-L1 glycosylation, promotes PD-L1 degradation, and improves T-cell-mediated tumor control when combined with checkpoint or CAR-T strategies.
-
Docetaxel Workflows for Tumor Models
2026-09-07
Docetaxel provides a practical microtubule-stabilizing benchmark for cancer chemotherapy research, from monolayer cytotoxicity assays to patient-derived gastric cancer assembloids. This guide translates its mechanism into reproducible dosing, orthogonal response measurements, and tumor–stroma experiments designed to expose treatment resistance.
-
Chlorpromazine HCl: Endocytosis & Neuropharmacology
2026-09-05
Chlorpromazine HCl is more than a conventional phenothiazine antipsychotic: it is a practical probe for dopamine receptor inhibition and clathrin-dependent cellular uptake. This guide shows how to integrate it into S2-cell infection assays, neuronal experiments, controls, and troubleshooting workflows without confusing endocytosis effects with general cytotoxicity.
-
Erastin: Mechanism and Ferroptosis Research Guide
2026-09-04
Erastin is a small-molecule ferroptosis inducer used to model iron-dependent oxidative cell death in cancer biology research. It connects RAS/BRAF-associated tumor vulnerability with system Xc⁻ inhibition, glutathione depletion, and lipid-peroxide accumulation, while product handling requires fresh DMSO preparation and controlled storage.
-
A-1210477: Translating MCL-1 Dependence
2026-09-04
A mechanistic and translational framework for using A-1210477 to distinguish MCL-1-dependent cancer cell survival from simple protein overexpression, validate mitochondrial apoptosis, and design more informative combination studies.